Abstract
Genetic Engineering & Biotechnology NewsVol. 43, No. 2 DepartmentsMaking Medicines Based on Transplanting Differentiated CellsAfter striking a $670M deal with Roche's Genentech, Lineage Cell Therapeutics aims to improve existing cell therapy programs and start new onesJonathan D. GrinsteinJonathan D. GrinsteinSearch for more papers by this authorPublished Online:10 Feb 2023https://doi.org/10.1089/gen.43.02.07AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 2Feb 2023 Information© 2023 by GEN PublishingTo cite this article:Jonathan D. Grinstein.Making Medicines Based on Transplanting Differentiated Cells.Genetic Engineering & Biotechnology News.Feb 2023.18-19.http://doi.org/10.1089/gen.43.02.07Published in Volume: 43 Issue 2: February 10, 2023PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
